The financing secures funds to advance the clinical development of EpiEndo’s lead compound EP395, which entered phase I clinical trials in April, through Phase IIa, targeting COPD as a primary indication
Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients four years of age and older
The group has a total of 320 ANDA approvals
It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
SAB-185 is currently being evaluated in NIH-sponsored Phase 2/3 adaptive trial
The company has also applied to DCGI for Emergency Use Authorization (EUA) for ZyCoVD, the world's first Plasmid DNA Vaccine
The company has tied up with OrbiMed as a financial partner for global reach
Purchase price of US $ 1.5 billion upfront and up to USD 500 million in success-based milestone payments
The drug is indicated for mild and transient episodes of heart block
Preclinical and early human data indicate BriLife may confer enhanced immunity against Delta variant
Subscribe To Our Newsletter & Stay Updated
